Pre-Intervention OSA measure 12 previously diagnosed with OSA (details not provided) AHI mean 22.3 Mean Sp02: 93.7%

Similar documents
Obstructive sleep apnea in children with syndromic craniosynostosis: long-term respiratory outcome of midface advancement

NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN CHILDREN. Dr. Nguyễn Quỳnh Anh Department of Respiration 1

Suchada Sritippayawan, MD Div. Pulmonology & Critical Care Dept. Pediatrics, Faculty of Medicine

CHALLENGES IN PEDIATRIC OBSTRUCTIVE SLEEP APNEA. Amy S. Whigham, MD Assistant Professor

Sleep Studies: Attended Polysomnography and Portable Polysomnography Tests, Multiple Sleep Latency Testing and Maintenance of Wakefulness Testing

Polysomnography (PSG) (Sleep Studies), Sleep Center

PORTABLE OR HOME SLEEP STUDIES FOR ADULT PATIENTS:

Obstructive Sleep Disordered Breathing in children and Growth

Pediatric OSA. Pediatric OSA: Treatment Options Beyond AT. Copyright (c) 2012 Boston Children's Hospital 1

Treatment of Obstructive Sleep Apnea (OSA)

Challenging Cases in Pediatric Polysomnography. Fauziya Hassan, MBBS, MS Assistant Professor Pediatric Pulmonary and Sleep

IEHP considers the treatment of obstructive sleep apnea (OSA) medically necessary according to the criteria outlined below:

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

Measuring Upper Airway Volume: Accuracy and Reliability of Dolphin 3D Software Compared to Manual Segmentation in Craniosynostosis Patients

Management of OSA. saurabh maji

Management of Upper Airway Obstruction in Pierre Robin Sequence

Monitoring: gas exchange, poly(somno)graphy or device in-built software?

Sleep Diordered Breathing (Part 1)

Circadian Variations Influential in Circulatory & Vascular Phenomena

Critical Review Form Diagnostic Test

Shyamala Pradeepan. Staff Specialist- Department of Respiratory and Sleep Medicine. John Hunter Hospital. Conjoint lecturer University of New Castle.

Ped e iat a r t i r c c S lee e p e A p A nea e a Surg r er e y

4/28/2017. Adult Obesity Rates

Prediction of sleep-disordered breathing by unattended overnight oximetry

PEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA)

Obstructive sleep apnea (OSA) is the periodic reduction

PBLD Table #14. Institution: Cleveland Clinic Children s Hospital, Cleveland, Ohio

Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea: A Meta-analysis.

Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

Update on sleep disorders in children

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Obstructive Sleep Apnea- Hypopnea Syndrome and Snoring: Surgical Options

Medicare C/D Medical Coverage Policy

Childhood Obstructive Sleep Apnea

Using Questionnaire Tools to Predict Pediatric OSA outcomes. Vidya T. Raman, MD Nationwide Children s Hospital October 201

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016

OSA in children. About this information. What is obstructive sleep apnoea (OSA)?

(To be filled by the treating physician)

Less invasive treatment of sleep-disordered breathing in children with syndromic craniosynostosis

Pediatric Sleep-Disordered Breathing

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update

A Deadly Combination: Central Sleep Apnea & Heart Failure

Pediatric Sleep Disorders

Questions: What tests are available to diagnose sleep disordered breathing? How do you calculate overall AHI vs obstructive AHI?

Bruxism: Revisiting an Old Problem with New Questions and Unique Solutions

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

Dr Alireza Yarahmadi and Dr Arvind Perathur Mercy Medical Center - Winter Retreat Des Moines February 2012

Obstructive sleep apnea Is it time for personalized medicine?

The Latest Technology from CareFusion

DECLARATION OF CONFLICT OF INTEREST

Obstructive sleep apnoea How to identify?

CPAP. The CPAP will be covered

Web-Based Home Sleep Testing

Treatment-related changes in sleep apnea syndrome in patients with acromegaly: a prospective study

Evaluation, Management and Long-Term Care of OSA in Adults

Sleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016

Online Supplement. Relationship Between OSA Clinical Phenotypes and CPAP Treatment Outcomes

Obstructive Sleep Apnoea

Surgical Options for the Successful Treatment of Obstructive Sleep Apnea

Upper Airway Obstruction

Obstructive sleep disordered breathing in 2- to 18-year-old children: diagnosis and management

QUESTIONS FOR DELIBERATION

18/06/2009 NZ Respiratory & Sleep Institute

Sleep apnea and bruxism

Obstructive sleep apnoea in children: perioperative considerations

Riley & Coll., Otolaryngol Head Neck Surg 1989; 101:

Airway and Airflow Characteristics In OSAS

MEDICAL POLICY. SUBJECT: POSITIVE AIRWAY PRESSURE DEVICES: CPAP, BiPAP, APAP AND NONINVASIVE POSITIVE PRESSURE VENTILATORS

Obstructive Sleep Apnea

Kaniethapriya A.S, Ganesh Prasad S.

High Flow Nasal Cannula in Children During Sleep. Brian McGinley M.D. Associate Professor of Pediatrics University of Utah

A comparative study of adult and pediatric polysomnography

Temperature controlled radiofrequency ablation for OSA

Karl Hörmann Thomas Verse Surgery for Sleep-Disordered Breathing

Overnight fluid shifts in subjects with and without obstructive sleep apnea

Emerging Nursing Roles in Collaborative Management of Sleep Disordered Breathing and Obstructive Sleep Apnoea

Case Report An Evaluation of a Novel Mask in Four Patients with Obstructive Sleep Apnea and Overlap Syndromes

Evaluation & Management of Pediatric Obstructive Sleep Apnea. Objective. Pediatric OSA. Pediatric OSA. #1 Cause of OSA in Children

Sleep Screening Questionnaire

Dr. Karan Madan Senior Resident

Just sleep apnoea? R.L. Riha. Department of Sleep Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK. Correspondence

JMSCR Vol 05 Issue 01 Page January 2017

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines

Introducing the WatchPAT 200 # 1 Home Sleep Study Device

Inspire Therapy for Obstructive Sleep Apnea. Clinical Data Update

Tolerance of Positive Airway Pressure following Site-Specific Surgery of Upper Airway

Perioperative Care in OSA Surgery

Enclosed on Page 5 is an authorization form to release your health information.

SKUP 3 : 6 and 24 Months Follow-up of Changes in Respiration and Sleepiness After Modified UPPP

Abbreviations: ADH: antidiuretic hormone ADHD: attention-deficit hyperactivity disorder ANP: atrial natriuretic peptide BNP: brain natriuretic

RESEARCH PACKET DENTAL SLEEP MEDICINE

MEDICAL POLICY. SUBJECT: POSITIVE AIRWAY PRESSURE DEVICES: CPAP, BiPAP, APAP AND NONINVASIVE POSITIVE PRESSURE VENTILATORS

Abdussalam Alahmari ENT Resident R2 KAUH 15/12/2015

Anesthetic Risks of Obstructive Sleep Apnea in Children

Sleep Disordered Breathing

Pediatric obstructive sleep apnea Adenotonsillectomy and beyond (a surgeon s perspective)

OSA OBSTRUCTIVE SLEEP APNEA

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

Transcription:

Coeugniet et al. 3 2014 Mitsukawa et al. 4 2013. Filiaci et al. 5 2013. Nout et al. 6 2012. 12-5 Apert 5 Crouzon 2 Pfeiffer 11-4 Crouzon 3 Pfeiffer 4 2 Crouzon 1 Apert 9-5 Crouzon All patients with known OSA undergoing distraction without maxillary osteotomy Series of those patients undergoing distraction early on the basis of having OSA Selected group from recent experience of 12 cases of advancement Cases undergoing midface advancement with PSG data 2.7 yrs (0.3-10) 2 yrs median (0.6 3) 5-9 yrs range 12.9yrs (1.5 23.2) 12 previously diagnosed with OSA (details not provided) AHI 22.3 Mean Sp02: 93.7% AHI 34.3 Sp02 nadir 80.2% ODI for seven patients with reliable data 21.9 Post-operative polysomnogrpahy demonstrated no OSA AHI 2.6 Mean Sp02: 98.5% AHI 3.3 Sp02 nadir 92.7% ODI for seven patients with reliable data 6.1 PSG details not reported. Reasonable numbers Complete of series. Moderate numbers. No long term follow up Incomplete, selected cases. Small numbers. Incomplete data. Selected cases. Xu et al. 7 2009. Ettinger et al. 8 2010. 2 - Syndrome not stated. 10 - Crouzon 7 Le Fort 3 osteotomy with known OSA. 5 year series of le fort 3, those with data 10.2 yrs 8.7 yrs (5.1-11) AHI 30.0 and 14.4 Mean Sp02 91 and 97 Nadir Sp02 68 and 62 AHI 4.4 and 1.1 Mean Sp02 99 and 98 Nadir Sp02 93 and 84. Very small numbers, selected cases AHI 20.6 (5.7-51.3) AHI 9.7 (2.2-22.7) Selected cases Gasparini et al. 9 2012 Flores et al. 10 2009. Mathijssen et al. 11 2006. 13-8 Crouzon 10 - Syndromes not stated. 59 - Syndromes not stated Series of all patients undergoing midface distraction who also have sleep data Patients with SDB in a series of those under 12.5 years undergoing Le Fort 3 distraction. Le Fort 3 distraction or monobloc procedure 8.9 yrs (1-16) 5.7 yrs 5.2 yrs 8 severe OSA, 4 moderate, 2 mild OACT score 85.9 2 tracheostomy 8 severe OSA 13 tracheostomy 7 severe OSA 14 mild OSA 4 mild, 10 no OSA OACT score 27.2 1 tracheostomy 2 moderate OSA 1 mild OSA 5 clinical (not defined) 5 tracheostomy 2 mild OSA 52 normal parameters Multiple outcome s, fully reported Variable outcome s. Subjective outcomes Variable outcome. Incomplete /

Bannink et al. 12 2010. Nelson et al. 13 2008. Fearon. 14 2005 11 - Crouzon 6 Pfeiffer 2 17 - Crouzon 6 Apert 6 Pfeiffer 4 Muenke 1 12 syndrome not stated Le Fort 3 distraction or monobloc procedure with sleep data Le Fort 3 distraction with evidence of SDB pre-op Le Fort 3 osteotomy at one centre. (inc revisions) 14.9 yrs (4.1-23.1) 10.4 yrs (2.7-17.4) 8 yrs (3-16) 25 normal parameters subjective assessment Variable s at different points, narrative of Narrative patients generally showing., inconsistent 6 tracheostomy. 2 central apnoea BIPAP Remaining 10: RDI 33.4 Nadir 82.8% AHI 12.1 RDI 24 Nadir 81% 1 tracheostomy 2 ongoing central apnoea. Remaining 15: RDI 12.6 Nadir 89.3% AHI 3.0 RDI 11 Nadir 89% Table 1: Outcomes from craniofacial surgery. PSG polysomnogrpahy. AHI apnoea hyponoea index. RDI respiratory disturbance index. ODI oxygen desaturation index. s Variable outcome s, but reasonable size group Selected patient group

Zandieh et 5.6 yrs al. 15 2013. Al-Saleh et al. 16 2010. Amonoo- Kuofi et al. 17 2009. Willington et al. 18 2012. Moore. 19 1993. 29-18 Apert, 6 Pfeiffer, 5 Crouzon. 7-4 Crouzon 3 Apert 25-10 Crouzon 9 Apert, 3 Pfeiffer 3 SaethreC 1 AntleyB 5 3 Crouzon 2 Apert 6 3 Crouzon 2 Apert all patients seen at one centre. 62% of patients had AT all patients with PSG data who had intervention (other intervention outcomes listed on other tables) all patients undergoing AT with pre and postop sleep studies all patients undergoing AT with pre and postop sleep studies all patients undergoing surgery for airway obstruction 4.3 yrs 4.5 yrs 4.0 yrs Not quoted 83 percent had Mean apnea/hypopnea index was not obstructive sleep apnea significantly different, and obstructive (42% severe, 19% sleep apnea persisted in 11 of 13 moderate, 22% mild) children Mean AHI: 21 Mean AHI: 15 AHI 18.8 (6.6-36.4) AHI 19.6 (0.4-76.9) General patient masked by one with grossly higher AHI. Significant latency between operation and post-op sleep study 7 had severe OSA 11 had moderate OSA 7 had mild OSA 10.9 ODI Variable s used. ODI quoted for three patients ( 28.3) Variable reports of desaturation frequency and nadir 15 (60%) demonstrated 3 had severe OSA 6 had moderate OSA 11 had mild OSA 5 had normal parameters 3.9 ODI Variable s used. ODI quoted for 3 patients (different 3 patients from preop ODI figures) ( 4.7) Matched reports on desatruation frequency and nadir. Significant Table 2: Outcomes from adenotonsillectomy. AT adenotonsillectomy. PSG polysomnogrpahy. ODI oxygen desaturation index. AHI apnoea hypopnoea index. No significant benefit Mixed Moderate Long follow up, comprehensive patient group, reasonable numbers Small studies. Latency prior to post-op sleep study Reasonable numbers, comprehensive Small study. Incomplete / variable outcome Small study Partially subjective outcomes

Moore. 19 Not 1993. quoted Al-Saleh et al. 16 2010. 9-3 Crouzon 2 Pfeiffer all patients undergoing surgery for airway obstruction 1 Apert All patients with PSG data who had intervention (other intervention outcomes listed on other tables) Table 3: Outcomes from palatal surgery. PSG polysomnogrpahy. AHI apnoea hypopnoea index. 10.3 yrs Pre-Intervention OSA Variable reports of desaturation frequency and nadir Matched reports on desatruation frequency and nadir. Significant palatal surgery AHI 9.0 AHI 2.0 palatal release Small study Partially subjective outcomes Single patient in this part of study

Ahmed et al. 20 1.0 yrs 2008. Randhawa et al. 21 2011. Kouga et al. 22 2014. 27-10 Crouzon 12 Apert 4 Pfeiffer 1 SaethreC 24-12 Crouzon 9 Apert 3 Pfeiffer 11 - Crouzon 7 Pfeiffer 3 Apert 1 all craniofacial patients at one centre managed with NPA all craniofacial patients at one centre managed with NPA patients undergoing NPA Not quoted 2.76 yrs (0.5-7.5) 17 severe OSA. 10 moderate OSA. Mean ODI:17.4 6 had concomitant adenoidectomy 10 severe OSA 6 moderate OSA 1 mild OSA All reported to have airway compromise Table 4: Outcomes from nasopharyngeal airway / nasal prong. NPA nasopharyngeal airway. ODI oxygen desaturation index. QoL quality of life. 3 moderate OSA. 24 mild OSA. Mean ODI: 4.8 3 moderate OSA. 14 mild OSA. Principle outcome was QoL. 88% kept for >6 months. 65% kept for >12 months 8/11 reported 64% kept for >6 months Consistent outcome. Reasonable numbers. Good follow up Significant overlap with above series. Main outcome was QoL Subjective outcome

Al-Saleh et 1.2 yrs al. 16 2010. Jarund et al. 23 1999. Gonsalez et al. 24 1996. 3-2 Crouzon 9 - Crouzon 4 Pfeiffer 2 8 - Crouzon 3 All patients with PSG data who had intervention (other intervention outcomes listed on other tables) Patients with confirmed OSA, all started on nasal CPAP Patients entered into prospective trial. 3 patients 3.6 yrs 2.2 15 years range AHI 16.2 (13.7-19.2) AHI 8.2 (1.4 17.4) Slight 2 were unable to commence CPAP. Of remaining 7: ODI: 37.1 (5-120) Mean O2 sats 91.1% (inc active and passive sleep) ODI 2.0 (0-6). 2 of 7 were unable to tolerate Mean O2 95.4% 2 of 8 were unable to tolerate Pfeiffer 2 Table 5: Outcomes with CPAP. PSG polysomnography. CPAP continuous positive airways pressure. AHI apnoea hypopnoea index. ODI oxygen desaturation index. Very small group Continuous series, complete outcome Prospective series, complete outcome